IGF2BP2 and neoplasm: A splice variant of the IMP2 gene, p62/IMP2-2, was originally identified as a tumor-associated auto-antigen with auto-antibodies against p62/IMP2-2 detected in HCC patients [13] and in several other cancer types [11, 12, 20].